Send Inquiry

Request To Call Back

Tigez 50 Mg Injection

Price 3033.0 INR/ Pack

Get a Price/Quote

MOQ : 7 Packs

Tigez 50 Mg Injection Specification

Pacakaging (Quantity Per Box)
1 vial per box

Origin of Medicine
Allopathic

Dosage Form
Injection

Indication
Complicated skin and soft tissue infections, complicated intra-abdominal infections

Salt Composition
Tigecycline 50 mg

Drug Type
Prescription

Ingredients
Tigecycline

Physical Form
Injection

Function
Antibacterial

Recommended For
Adults

Dosage
As directed by physician

Dosage Guidelines
Intravenous use only

Quantity
1 vial

Storage Instructions
Store below 25C, protected from light

Color
Yellow to orange powder

Route of Administration
Intravenous

Prescription Required
Yes

Reconstitution Required
Yes, with sterile water for injection

Therapeutic Class
Antibiotics

Packing Type
Glass vial with stopper

Shelf Life
24 months

Tigez 50 Mg Injection Trade Information

Minimum Order Quantity
7 Packs

Payment Terms
Telegraphic Transfer (T/T), Cash in Advance (CID), Cash Advance (CA)

Supply Ability
1000 Packs Per Week

Delivery Time
6 Days

Sample Available
Yes

Sample Policy
If order is confirmed we will reimburse the sample cost

Main Export Market(s)
Asia, Australia, Central America, South America, Eastern Europe, Western Europe, North America, Africa, Middle East

Main Domestic Market
All India

About Tigez 50 Mg Injection

1. Technical Specifications

Attribute	Details
Brand Name	Tigez Injection
Generic Name	Tigecycline
Strength	50 mg per vial
Dosage Form	Lyophilized powder for reconstitution (IV injection/infusion)
Packaging Size	Single vial
Packaging Type	Glass vial with sterile powder
Medicine Type	Allopathic, Antibiotic
Manufacturer	Natco Pharma Ltd.
Distributed By	Authorized distributors

2. Product Description

Tigez 50 mg Injection contains Tigecycline, a broad-spectrum glycylcycline antibiotic structurally related to tetracyclines. It acts by binding to the 30S ribosomal subunit, thereby inhibiting bacterial protein synthesis and preventing bacterial growth.

It is given intravenously after reconstitution and is reserved for complicated infections due to its broad activity against multi-drug resistant organisms.

3. Product Highlights

Attribute	Details
Therapeutic Category	Glycylcycline antibiotic
Application Area	Severe bacterial infections resistant to standard antibiotics
Mechanism of Action	Inhibits bacterial protein synthesis by binding to 30S ribosomal subunit
Administration	Intravenous infusion (over 3060 minutes) after reconstitution with sterile solution
Storage Conditions	Store below 25C; protect from light; reconstituted solution stable for limited time only

4. Therapeutic Uses

Complicated intra-abdominal infections
Complicated skin and soft tissue infections
Community-acquired pneumonia (when alternatives are unsuitable)
Active against many resistant pathogens: MRSA, VRE, ESBL-producing organisms

5. Side Effects

Common:

Nausea, vomiting, diarrhea
Headache, dizziness
Injection site reactions
Increased liver enzymes

Serious / Severe:

Pancreatitis
Severe hepatic impairment
Increased risk of mortality in some severe infections (black box warning)
Superinfections including Clostridioides difficile-associated diarrhea
Hypersensitivity or anaphylaxis (rare)

6. Precautions

Liver Function: Dose adjustment required in severe hepatic impairment. Monitor liver enzymes regularly.
Pregnancy & Breastfeeding: Contraindicated; potential teratogenic effects and excretion in breast milk.
Children: Not recommended in patients <8 years due to tooth discoloration and bone growth issues.
Drug Interactions: Use with caution alongside anticoagulants (may increase INR). Avoid with other hepatotoxic agents.
Resistance: Not for routine use in mild infections; reserve for resistant cases.
Mortality Risk: Studies show higher mortality in serious infectionsshould be used when no alternatives are available.

Therapeutic Application of Tigez 50 Mg Injection

Tigez 50 Mg Injection is utilized in clinical settings to manage severe bacterial infections, particularly those affecting the skin, soft tissue, and abdominal area. Its broad-spectrum antibacterial properties make it effective against various resistant pathogens, underscoring its significance for patients with complicated health conditions seeking targeted therapy.

Proper Use and Preparation

Before administration, Tigez 50 Mg Injection must be reconstituted with sterile water for injection as per the guidelines. This process ensures the correct concentration for intravenous delivery. Only trained healthcare professionals should handle preparation and administration to optimize efficacy and minimize risks associated with improper use.

Safe Storage and Shelf Life

Maintaining the stability of Tigez 50 Mg Injection requires strict storage below 25C and protection from light. Each glass vial is engineered to preserve the medicines integrity for up to 24 months. Following these instructions reduces the risk of degradation, ensuring the medications optimal performance when needed.

FAQs of Tigez 50 Mg Injection:

Q: How should Tigez 50 Mg Injection be prepared prior to use?

A: Tigez 50 Mg Injection must be reconstituted with sterile water for injection according to healthcare guidelines before administration. Only trained medical staff should perform this step to ensure safety.

Q: What conditions does Tigez 50 Mg Injection treat?

A: This medication is recommended for adults suffering from complicated skin and soft tissue infections or complicated intra-abdominal infections, as prescribed by a doctor.

Q: When should Tigez 50 Mg Injection be administered?

A: Tigez 50 Mg Injection should be given only when prescribed by a physician, following their specific dosage schedule for intravenous infusion.

Q: Where should Tigez 50 Mg Injection be stored before use?

A: Store the vial below 25C, protected from light, to maintain its efficacy and shelf life until its expiration date.

Q: What is the correct route of administration for Tigez 50 Mg Injection?

A: This injection is intended for intravenous use only and must not be administered by other routes.

Q: What is the primary benefit of Tigez 50 Mg Injection in treatment regimens?

A: The main benefit of Tigez 50 Mg Injection is its effectiveness against resistant bacterial pathogens causing severe infections, providing targeted antibacterial action for complicated cases.